We built Hoot because PSPs aren't solving the real problem.
Bob Miglani spent 23 years at Pfizer watching brands invest hundreds of millions in PSPs and patient support, and still lose 40–50% of patients at the pharmacy counter. The drug worked. But patients hesitated, got confused, and abandoned therapy before it had a chance to help.
Dr. Shefali Miglani saw it from the clinical side: life-changing therapies prescribed but never filled. The appointment was too short, the complexity too high, and no physician-led voice followed patients home to close the gap.
Nothing moved the needle.
Prescriptions still go unfilled. Patients still abandon after month one. The gap between "prescribed" and "on therapy" keeps widening, because no one is educating patients in the physician's voice, at scale, at home.
